XOMA Corp

NASDAQ XOMAP

Data sourced from iex and EODHD
Download Data

XOMA Corp Gross Profit 1 year YoY Change (%) for the year ending December 31, 2023: -34.94%

XOMA Corp Gross Profit 1 year YoY Change (%) is -34.94% for the year ending December 31, 2023, a 58.60% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations. The measure "Change (%)" refers to the percentage change in the value of a financial metric between two time points. This measure provides a relative perspective on the magnitude of change.
  • XOMA Corp Gross Profit for the year ending December 31, 2022 was USD 5.93 M, a -84.39% change year over year.
  • XOMA Corp Gross Profit for the year ending December 31, 2021 was USD 37.99 M, a 30.03% change year over year.
  • XOMA Corp Gross Profit for the year ending December 31, 2020 was USD 29.21 M, a 59.04% change year over year.
  • XOMA Corp Gross Profit for the year ending December 31, 2019 was USD 18.37 M.
NASDAQ: XOMAP

XOMA Corp

CEO -
IPO Date Dec. 16, 2020
Location United States
Headquarters 2200 Powell Street, EmeryVille, CA, United States, 94608
Employees 13
Sector Healthcare
Industry Biotechnology
Description

XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

Similar companies

XOMAO

XOMA Corporation

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email